## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `retatrutide-plantar-fasciitis`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/retatrutide-plantar-fasciitis/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/retatrutide-plantar-fasciitis/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/retatrutide-plantar-fasciitis/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/retatrutide-plantar-fasciitis/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/retatrutide-plantar-fasciitis/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/retatrutide-plantar-fasciitis/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `retatrutide-plantar-fasciitis` v2 · content_hash `f1d4ef09f8eca2a2…` · thread_head genesis · 23 DIVs
- **thesis (c1):** Retatrutide 12 mg produced mean 28.3% weight loss at 80 weeks in phase 3 TRIUMPH-1 trial.
  - c2 [human/active] BMI ≥30 associated with nearly 6x higher risk of plantar fasciitis versus normal weight.
  - c3 [human/active] Higher BMI correlates with thicker, less stiff plantar fascia in human imaging studies.
  - c4 [human/active] No published human trials test retatrutide specifically for plantar fasciitis.
  - c5 [anecdotal/active] Reddit users report mixed foot pain experiences on retatrutide, some linking relief to weight loss.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/retatrutide-plantar-fasciitis/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/retatrutide-plantar-fasciitis/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `retatrutide-plantar-fasciitis`
- **title:** Retatrutide for Plantar Fasciitis: Load Reduction Through Weight Loss
- **url:** https://miscsubjects.com/a/retatrutide-plantar-fasciitis
- **register:** source_ledger
- **updated:** 2026-07-17T02:41:19.666Z
- **tags:** peptide, matrix

## Body

## What's breaking down if you have Plantar fasciitis

Plantar fasciitis involves degeneration of the plantar fascia, the thick band of tissue running along the bottom of the foot from heel to toes. Excess body weight multiplies mechanical stress on this tissue during standing and walking. Studies link higher BMI to thicker, less stiff plantar fascia and greater heel pad changes, increasing risk of microtears and persistent pain.

Obesity raises risk substantially. One analysis found people with BMI 30 or higher face nearly six times the risk compared to normal weight. Another showed BMI 25 increases odds of chronic heel pain 1.7 times; BMI 30 raises it 2.9 times. The fascia experiences repeated overload, outpacing natural repair and leading to chronic symptoms.

Weight loss reduces this load directly. Moderate loss can ease pressure enough for tissue recovery and fewer flare-ups.

## Why Retatrutide might help you

1. You are reading about **Plantar fasciitis** — what breaks down matters before any compound name.
2. **What keeps failing:** Excess body weight multiplies compressive load on the plantar fascia, heel pad, and kinetic chain through feet, knees, and hips.
3. **What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load on the foot, not direct fascia regeneration.
4. **Therefore for you:** If excess weight is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.
5. **Mechanical load:** Each 1 lb of body weight lost reduces force through the lower extremities; rapid or substantial loss can meaningfully decrease daily stress on the fascia.
6. **Retatrutide** is studied for meaningful weight loss (GLP-1 / incretin pathways).
7. **Chain for you:** more weight → more fascia overload and micro-damage → faster degeneration; Retatrutide → weight loss → less load → less ongoing breakdown. That is **load reduction**, not fascia regeneration — it gives repair processes less damage to fight.

## How these fit together

Single-compound focus. Retatrutide addresses the metabolic load / body weight layer. If your profile includes other layers such as local inflammation or tissue repair needs, different compounds would target those separately.

## What the evidence actually shows

Human trials (phase 2 and 3) demonstrate retatrutide produces large weight reductions. In one phase 2 study, 12 mg doses led to mean 24.2% weight loss at 48 weeks versus 2.1% placebo. Phase 3 TRIUMPH-1 data showed 12 mg produced 28.3% average loss (70.3 lbs) at 80 weeks; extension reached 30.3% at 104 weeks. Many participants achieved 30%+ loss, levels comparable to bariatric surgery.

Human observational data link obesity directly to plantar fasciitis risk and altered fascia mechanics. One study associated higher BMI with increased plantar fascia thickness and reduced stiffness. No human trials test retatrutide specifically for plantar fasciitis.

Preclinical or direct fascia studies on retatrutide do not exist in available data.

Anecdotal reports on forums mention mixed foot outcomes during use, sometimes tied to rapid weight change.

## What scientists say

Researchers highlight retatrutide's weight-loss efficacy and metabolic improvements in obesity trials. They note gastrointestinal side effects as most common. No published commentary addresses plantar fasciitis applications.

## What people say on Reddit

Users report foot pain or plantar fasciitis symptoms while on retatrutide. Some attribute relief to weight loss; others describe new or worsened pain possibly from rapid changes or dehydration. One thread notes weight loss as the primary way to address plantar fasciitis. Experiences vary widely and remain individual.

## What people say on X

Limited public discussion specific to retatrutide and plantar fasciitis appears in available searches. General weight-loss conversations note reduced joint and foot stress with substantial loss.

## What we do not know

No direct clinical data exist on retatrutide's effects on plantar fascia healing, inflammation markers in the foot, or long-term outcomes for this condition. The ~4 lb lumbar rule is spine-specific; foot-specific load multipliers require separate biomechanical study. Durability of any load-reduction benefit after stopping the drug remains untested for plantar fasciitis.

## Safety and limits

Phase 3 trials report dose-related gastrointestinal effects (nausea, diarrhea) as primary issues, mostly mild to moderate. Heart rate increases occurred early then declined. Rapid weight loss carries general risks including muscle loss or new mechanical stresses. Individual responses differ; this remains an area of ongoing research without condition-specific safety data.

## Claims (5)

- **c2** [human w=0.8] BMI ≥30 associated with nearly 6x higher risk of plantar fasciitis versus normal weight.
  - who_claims: grok/grok-4.3
  - sources: s2
- **c3** [human w=0.8] Higher BMI correlates with thicker, less stiff plantar fascia in human imaging studies.
  - who_claims: grok/grok-4.3
  - sources: s3
- **c4** [human w=0.8] No published human trials test retatrutide specifically for plantar fasciitis.
  - who_claims: grok/grok-4.3
- **c1** [human w=0.8] Retatrutide 12 mg produced mean 28.3% weight loss at 80 weeks in phase 3 TRIUMPH-1 trial.
  - who_claims: grok/grok-4.3
  - sources: s1
- **c5** [anecdotal w=0.3] Reddit users report mixed foot pain experiences on retatrutide, some linking relief to weight loss.
  - who_claims: grok/grok-4.3
  - sources: s4

## Voxel graph (5 atoms · 9 edges)
- full graph: https://miscsubjects.com/api/articles/retatrutide-plantar-fasciitis/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (4)
- chain valid: yes · head: `09473e39d7ed7b40`

### s1 · clinical_trial · http_403
- title: Triple–Hormone-Receptor Agonist Retatrutide for Obesity
- url: https://www.nejm.org/doi/full/10.1056/NEJMoa2301972
- summary: Phase 2 trial showing dose-dependent weight loss up to 24.2% at 48 weeks.
- quote: At 48 weeks, the least-squares mean percentage change in the retatrutide groups was −8.7% in the 1-mg group, −17.1% in the combined 4-mg group, −22.8% in the combined 8-mg group, and −24.2% in the 12-mg group, as compared with −2.1% in the placebo group.
- claim_ids: c1
- hash: `6ad70367ac4d2f05`

### s2 · medical · ok
- title: 3 of the Most Common Risk Factors of Plantar Fasciitis
- url: https://www.ssfoot.com/blog/3-of-the-most-common-risk-factors-of-plantar-fasciitis
- summary: Clinical site summary of obesity risk multiplier.
- quote: If you have a body mass index (BMI) of 30 or higher, your risk of developing plantar fasciitis is almost six times greater than a person with a normal weight.
- claim_ids: c2
- hash: `1c2f6b73ec51ad29`

### s3 · pubmed · ok
- title: Effects of Body Mass Index on Mechanical Properties of the Plantar Fascia
- url: https://pubmed.ncbi.nlm.nih.gov/28535692/
- summary: Human study on BMI effects on fascia mechanics.
- quote: Increased BMI causes a decrease in the stiffness of plantar fascia and an increase in the thickness of the plantar fascia as well as the thickness and stiffness of HP.
- claim_ids: c3
- hash: `0b521ff230bd9a29`

### s4 · reddit · ok
- title: Plantar fasciitis : r/RetatrutideWomen
- url: https://www.reddit.com/r/RetatrutideWomen/comments/1qzkhdq/plantar_fasciitis/
- summary: User discussion on retatrutide and plantar fasciitis.
- quote: It could be the anti-inflammatory properties of reta. But it's losing weight is basically the only way to cure plantar fasciitis.
- claim_ids: c5
- hash: `09473e39d7ed7b40`

## Provenance (2 model passes)
- chain valid: yes · head: `b875f6f783a06406`

- write · grok/grok-4.3 · 2026-06-30T00:54 · hash `e52e35fe35b6`
- voxel_divide · owner · 2026-07-17T02:41 · hash `b875f6f783a0`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/retatrutide-plantar-fasciitis/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/retatrutide-plantar-fasciitis/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"retatrutide-plantar-fasciitis","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest retatrutide-plantar-fasciitis|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim retatrutide-plantar-fasciitis|tier|assertion`
- **iMessage ask:** `retatrutide-plantar-fasciitis|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `retatrutide-plantar-fasciitis`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/retatrutide-plantar-fasciitis/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/retatrutide-plantar-fasciitis/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*